138 related articles for article (PubMed ID: 28641620)
1. [Role of Microparticles Derived from Acute Promyelocytic Leukemia Cells in Coagulopathy].
Zhang YM; Chen B; Wu LY; Hou JX; Fu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):693-698. PubMed ID: 28641620
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
[TBL] [Abstract][Full Text] [Related]
3. [Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells].
Guo W; Zhu J; Wang H
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):453-5. PubMed ID: 11721405
[TBL] [Abstract][Full Text] [Related]
4. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
5. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
6. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
[TBL] [Abstract][Full Text] [Related]
7. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
Zhu J; Guo WM; Yao YY; Zhao WL; Pan L; Cai X; Ju B; Sun GL; Wang HL; Chen SJ; Chen GQ; Caen J; Chen Z; Wang ZY
Leukemia; 1999 Jul; 13(7):1062-70. PubMed ID: 10400422
[TBL] [Abstract][Full Text] [Related]
8. [Effect of arsenic trioxide and daunorubicin on procoagulant activity of acute promyelocytic leukemia cells].
Shi JL; Li JM; Hou JX; Cao FL; Liu SC; Zhou J; Gao CY; Wang J; Tan XY; Li JN; Liu Y; Liu Y; Ma RS; Yang X
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1095-9. PubMed ID: 22781766
[TBL] [Abstract][Full Text] [Related]
9. [The impact of arsenic trioxide or all-trans retinoic acid treatment on coagulopathy in acute promyelocytic leukemia].
Zhang X; Zhou H; Song S; Qiao Z; Yang L; Hu Y
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):829-33. PubMed ID: 16206674
[TBL] [Abstract][Full Text] [Related]
10. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
Ma G; Liu F; Lv L; Gao Y; Su Y
Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
[TBL] [Abstract][Full Text] [Related]
11. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
[TBL] [Abstract][Full Text] [Related]
13. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
[TBL] [Abstract][Full Text] [Related]
14. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
[TBL] [Abstract][Full Text] [Related]
15. [Tissue factor expression during all-trans retinoic acid or arsenic trioxide treatment in acute promyelocytic leukemia].
Zhao W; Wang H; Guo W
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):473-6. PubMed ID: 11189487
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
17. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
18. The influence of joint application of arsenic trioxide and daunorubicin on primary acute promyelocytic leukaemia cells and apoptosis and blood coagulation of cell strain.
Zhang X; Qin N; Chen X; Guo S
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1075-8. PubMed ID: 26051726
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
20. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
Wu F; Wang X; Zhao W; Wang H; Shen Z
Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
